1. Woodward DF, Andrews SW, Burk RM, Garst ME, inventors; Allergan, Inc, assignee. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents. US Patent 5352708. Oct 4, 1994.
2. Replacement of the carboxylic acid group of prostaglandin F2α with a hydroxyl or methoxy substituent provides biologically unique compounds;Woodward;Br J Pharmacol,2000
3. Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2;Yu;J Biol Chem,1997
4. Laibovitz RA, VanDenburgh AM, Felix C, et al. Comparison of the Ocular Hypotensive LipidTM AGN 192024 with timolol: dosing, efficacy and safety evaluation of a novel compound for glaucoma management. Arch Ophthalmol (In press).
5. Timolol hemihydrate vs timolol maleate to treat ocular hypertension and open-angle glaucoma;DuBiner;Am J Ophthalmol,1996